Rizatriptan Related Products
Axios Research stands at the forefront of pharmaceutical reference standards ingenuity, providing high quality Rizatriptan Reference Standards. These include both pharmacopeial and non-pharmacopeial Rizatriptan impurities, metabolites, stable isotope products, and nitrosamines. Our Rizatriptan impurity reference standards are essential for pharmaceutical research, aiding in product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They are also used in identifying unknown impurities and evaluating genotoxic potential. Our Rizatriptan related products are meticulously characterized and come with a comprehensive Certificates of Analysis (COA) and analytical data that comply with regulatory standards.Rizatriptan EP Impurity I Benzoate
M.F.
M.W. 255.33 122.12
CAT# AR-R01868
CAS# 144034-84-4 (free base)
Rizatriptan EP Impurity I-d3 Benzoate
M.F.
M.W. 258.34 122.12
CAT# AR-R01880
CAS# 144034-84-4 (non-d free base)
Rizatriptan EP Impurity I-13C-d3 Benzoate
M.F.
M.W. 259.33 122.12
CAT# AR-R01881
CAS# 144034-84-4 (non-labelled free base)
1-[(4-Hydrazinophenyl)methyl]-1H-1,2,4-triazole Hydrochloride
M.F.
M.W. 189.22 36.5
CAT# AR-R02061
CAS# 154748-67-1